Peptide-Functionalized Lipid Nanoparticles for Targeted Systemic mRNA Delivery to the Brain
Nano Letters · 15.01.2025 · 25 (2) · 800-810
DOI: 10.1021/acs.nanolett.4c05186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, online erschienen am 17.12.2024. Verfasst von Emily L Han und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States. Hauptthemen laut MEDLINE: Nanoparticles, RNA, Messenger, Brain, Lipids. Die Arbeit wurde bisher 169-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: NCATS NIH HHS, Wellcome Fund, NIDCR NIH HHS.
Abstract (Originalsprache)
Systemic delivery of large nucleic acids, such as mRNA, to the brain remains challenging in part due to the blood-brain barrier (BBB) and the tendency of delivery vehicles to accumulate in the liver. Here, we design a peptide-functionalized lipid nanoparticle (LNP) platform for targeted mRNA delivery to the brain. We utilize click chemistry to functionalize LNPs with peptides that target receptors overexpressed on brain endothelial cells and neurons, namely the RVG29, T7, AP2, and mApoE peptides. We evaluate the effect of LNP targeting on brain endothelial and neuronal cell transfection in vitro, investigating factors such as serum protein adsorption, intracellular trafficking, endothelial transcytosis, and exosome secretion. Finally, we show that LNP peptide functionalization enhances mRNA transfection in the mouse brain and reduces hepatic delivery after systemic administration. Specifically, RVG29 LNPs improved neuronal transfection in vivo, establishing its potential as a nonviral platform for delivering mRNA to the brain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
- Center for Fetal Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, United States.
- Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
- Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
- Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
ORCID-Profile: Emily L Han, Sophia Tang, Dongyoon Kim, Amanda M Murray, Kelsey L Swingle, Alex G Hamilton, Kaitlin Mrksich, Marshall S Padilla, Rohan Palanki, Jacqueline J Li, Michael J Mitchell
Förderung
- NCATS NIH HHS
- Wellcome Fund
- NIDCR NIH HHS
- NHLBI NIH HHS
- National Science Foundation Graduate Research Fellowship Program
- National Heart, Lung, and Blood Institute
- National Institute of Dental and Craniofacial Research
- American Cancer Society
Zitieren
APA
Han, E. L., Tang, S., Kim, D., Murray, A. M., Swingle, K. L., Hamilton, A. G., Mrksich, K., Padilla, M. S., Palanki, R., Li, J. J., & Mitchell, M. J. (2025). Peptide-Functionalized Lipid Nanoparticles for Targeted Systemic mRNA Delivery to the Brain. Nano Letters, 25(2), 800-810. https://doi.org/10.1021/acs.nanolett.4c05186
Vancouver
Han EL, Tang S, Kim D, Murray AM, Swingle KL, Hamilton AG, et al. Peptide-Functionalized Lipid Nanoparticles for Targeted Systemic mRNA Delivery to the Brain. Nano Letters. 2025;25(2):800-810. doi:10.1021/acs.nanolett.4c05186
BibTeX
@article{Han2025,
author = {Han, Emily L and Tang, Sophia and Kim, Dongyoon and Murray, Amanda M and Swingle, Kelsey L and Hamilton, Alex G and Mrksich, Kaitlin and Padilla, Marshall S and Palanki, Rohan and Li, Jacqueline J and Mitchell, Michael J},
title = {Peptide-Functionalized Lipid Nanoparticles for Targeted Systemic mRNA Delivery to the Brain},
journal = {Nano Letters},
year = {2025},
volume = {25},
number = {2},
pages = {800--810},
doi = {10.1021/acs.nanolett.4c05186}
}
EUVIMED